北京口岸进口抗感染药物的现状和趋势分析

Status analysis of imported anti-infective drugs in Beijing port

目的了解北京口岸抗感染类药物进口情况的现状及变化趋势。方法对2008年11月1日至2011年10月31日北京口岸进口的抗感染类药物的数量和品种进行定量研究并做出相关分析。结果2008年11月1日至2009年10月31日（2009年），通过北京口岸进口的药品总批次为3995批，其中进12I抗感染药物877批；2009年11月1日至2010年10月31日（2010年）进口药品总批次为3756批，抽检件数为12704件，包括进口抗感染药物1157批；2010年11月1日至2011年10月31日（2011年）进口药品总批次为3806批，其中进口抗感染药物1182批。进口抗感染类药物进口量逐年递增且品种较单一，喹诺酮类和头孢菌素类药物占抗感染类药物比重最大。结论进口抗感染类药物的数量变化，与医药市场行业发展和相关政策出台密切相关。

Objective To understand the status of anti-infective drugs imported in the past three years at Beijing port. Methods The quantity and variety of anti-infective drugs which were imported from November 1, 2008 to October 31, 2011 at Beijing port were analyzed. Results The total batches of drugs imported by the Beijing port were 3995 from November 1, 2008 to October 31, 2009, of which imported anti-infective drugs were 877 batches; the total batches of imported drugs were 3756 from November 1, 2009 to October 31, 2010, including 1157 batches of imported anti-infective drugs ; the total batches of imported drugs were 3806 from November 1, 2010 to October 31, 2011, including 1182 batches of imported anti-infective drugs. The quantity of imported anti- infective drugs increased year by year but species was single, quinolone and cephalosporin drugs accounted the largest proportion of anti-infective drugs. Conclusion The quantity of imported anti-infective drugs is closely related to the development of pharmaceutical market industry and government policies.